INSULET CORP (PODD)
Surgical & Medical Instruments & Apparatus · Healthcare · $10.4B
Intrinsic Value (Consensus)
$53.12
Current Price
$147.69
Margin of Safety
-64%
64% Above Intrinsic Value
Value: $53
Price: $148
Valuation Model Estimates
Current Price: $147.69
DCF (Discounted Cash Flow)
$68.03
Graham Number
$41.05
Earnings Power Value
$33.79
Relative Value (P/E)
$69.60
Dividend Discount Model
Not applicable
—
Consensus Value
$53.12
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
52
Profitability
22/25
Strength
19/25
Valuation
7/25
Growth
4/25
Financial Health Signals
Declining revenue — top line is shrinking
Key Financials
- EPS (TTM)
- $3.48
- EPS (Forward)
- $3.55
- Book Value
- $21.53
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 16.3%
- Debt/Equity
- 93%
- Revenue Growth
- -3.9%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance